trending Market Intelligence /marketintelligence/en/news-insights/trending/ZBjm9-cIP7IFn9TX8Xt_AA2 content esgSubNav
In This List

CytoDyn to raise $1.2M from offering

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


CytoDyn to raise $1.2M from offering

CytoDyn Inc. plans to raise approximately $1.2 million via the sale of 1,880,765 shares priced at 65 cents apiece.

The shares will come bundled with 0.5 of a purchase warrant. Each whole warrant will be exercisable for an additional stock in the company at 75 cents apiece.

The biotechnology company intends to use the net proceeds from the transactions to fund clinical trials for its lead product candidate and for general corporate purposes.